Bristol-Myers Squibb has appointed Peter Arduini to its board of directors, effective 1 April.
Arduini brings over 25 years of medical technologies expertise to the biopharmaceutical company’s board and currently serves as president, chief executive officer and director of Integra LifeSciences, a US-based medical technology company.
Prior to joining Integra LifeSciences, Arduini held the roles of corporate vice president and president of medication delivery at Baxter Healthcare from 2005 until 2010, overseeing its inpatient acute care in hospital markets portfolio.
Lamberto Andreotti, chairman of BMS, said: “Pete is a confident and engaging leader who has delivered tremendous results throughout his career.
“His commercial, financial and operational experience, along with a deep understanding of healthcare, make him an ideal choice for our board.”
Arduini will also become a member of BMS’ audit committee of the board of directors on 3 May.